A Phase III, Double-Blind, Randomized, Placebo-Controlled Study of Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
Determination of efficacy and safety of porfiromycin versus placebo as an adjuvant to radiotherapy in postoperative head and neck a cancer patients as well as assessment of population pharmacokinetic parameters.
Epistemonikos ID: e36c5d4e53305207acfc163e05659dea9d4d8223
First added on: May 11, 2024